SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-14-072832
Filing Date
2014-10-21
Accepted
2014-10-21 20:41:30
Documents
2
Period of Report
2014-10-21

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6115
2 EX-24.1 ex-24d1.htm EX-24.1 18087
  Complete submission text file 0001104659-14-072832.txt   26267
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701
Business Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701 7 495 970 0032
Public Joint Stock Co Pharmstandard (Reporting) CIK: 0001598754 (see all company filings)

State of Incorp.: 1Z | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 141166623

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Reporting) CIK: 0001598762 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36694 | Film No.: 141166624